Arsenal Medical is a privately-held biotechnology company focused on the development of therapeutic products based on its proprietary BioActive Composites platform.
Bioactive Composites are combinations of materials that elicit targeted therapeutic effects. Our biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. They offer precise, tailored dosing of drugs, mechanical and biochemical compatibility with tissues, and complete bioabsorption.
Arsenal integrates chemistry, materials engineering, drug delivery, and device engineering with a mechanistic understanding of disease biology. The company is the first entrepreneurial collaboration between pioneering scientists George Whitesides and Bob Langer.
Arsenal Medical creates value through:
- • Internally developing and commercializing therapeutic products powered by BioActive Composites platform. technology
- • Strengthening our BioActive Composites technology portfolio through strategic R&D and intellectual property development.
- • Forming strategic partnerships that leverage the BioActive Composites platform through out-licensing.